Comment
. 2001 May 1;19(9):2578; author reply 2580-2.
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
- PMID: 11331343
Item in Clipboard
Comment
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
J Clin Oncol.
.
No abstract available
Comment on
-
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.J Clin Oncol. 2000 Nov 15;18(22):3748-57. doi: 10.1200/JCO.2000.18.22.3748. J Clin Oncol. 2000. PMID: 11078487 Clinical Trial.
-
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.J Clin Oncol. 2000 Nov 15;18(22):3758-67. doi: 10.1200/JCO.2000.18.22.3758. J Clin Oncol. 2000. PMID: 11078488 Clinical Trial.